819 / 1068
EORTC 22921 Trial
Local recurrence as a
first event at 5 years
was
17.1%
in the
preoperative-
radiotherapy group vs
8.7%, 9.6% and 7.6%
in the group receiving
preoperative
chemoradiotherapy
17.1%
03/01/13
and postoperative
chemotherapy.